Case Report
Copyright ©The Author(s) 2021.
World J Clin Oncol. Apr 24, 2021; 12(4): 262-271
Published online Apr 24, 2021. doi: 10.5306/wjco.v12.i4.262
Table 1 Hepatic tumor cases reported to have triple (hepatocellular, cholangiocytic, and neuroendocrine) differentiation
Cases of liver tumor with triple differentiation described in the literature
Ref.
Chinese male patients (n = 2; average age: 57.5 yr). Both were positive for hepatitis B and exhibited hepatic tumors with triple differentiation.He et al[8], 2013
An otherwise healthy 19-year-old Caucasian male developed a large hepatic tumor showing triple differentiation.Beard et al[7], 2017
A 65-year-old female with a previous history of hepatitis C and rectal “carcinoid” developed a hepatic tumor with triple differentiation.Current case report
Table 2 Timeline of patient’s history and medical interventions
Dates
Summary from initial and follow-up visits
Diagnostic testing
Intervention/results
2012 and 2017Routine colonoscopy1 cm polypoid lesion in rectumRemoved endoscopically → well-differentiated neuroendocrine tumor
May/June 2019Presents with abdominal painCT, MRI, FDG/PET → two liver lesionsCT-guided biopsy → poorly differentiated carcinoma with neuroendocrine features
September 2019Presents for surgical interventionPresents for surgical interventionResection of the 2 liver lesions → Final diagnosis of combined liver tumor
October 2019Post-surgical follow-upCT and FDG/PET → New liver lesion in domeAdditional imaging was advocated
March 2020MRI revealed new portocaval lymphadenopathyEndoscopic ultrasound-guided FNA of lymph nodesLymph nodes positive for metastatic adenocarcinoma
May 2020Final oncology consultation after imagingInitiation of cisplatin and gemcitabine chemotherapy
October 2020Presents to hospital with altered mental statusFound to be in shock due to a combination of GI bleed/sepsisPatient expired, despite medical treatment